Clinical Trial Update: Anti-E1E2 (D32.10 Epitope-binding) Antibodies Status Prior Therapy Favors Direct-acting Antiviral Treatment Efficacy

View source ↗

Summary

A completed trial evaluating Anti-E1E2 (D32.10 epitope-binding) antibodies suggests prior therapy favors the efficacy of direct-acting antivirals in chronic hep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Anti-E1E2 (D32.10 Epitope-binding) antibodies (Anti-E1E2 D32.10 epitope-binding antibody)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Chronic Hepatitis c | Status: COMPLETED